The RUFUS Trial: Could the Benzodiazepine Antidote Flumazenil be used Safely and Effectively Pre-hospital?

The Drugs Research Network Scotland (DRNS) held a webinar on the 5th of May 2026, “The RUFUS Trial: Could the Benzodiazepine Antidote Flumazenil be used Safely and Effectively Pre-hospital?” presented by Professor Michael Eddleston discussing the RUFUS study and its exploration of flumazenil as a potential treatment for suspected benzodiazepine overdose in emergency settings. The session highlighted the clinical background to the trial, the importance of improving overdose care, and the potential implications for pre-hospital practice and patient safety.